NCT03785470

Brief Summary

The purpose of this study is to determine if short-term adoption of a Westernized lifestyle characterized by physical inactivity and increased consumption of fructose will result in metabolic and vascular dysfunction. Healthy individuals aged 18-45 years old will undergo an acute period of physical inactivity (10 days) coupled with increased fructose consumption. Augmented fructose consumption will be achieved via commercially available soda beverages which are high in fructose. Vascular and metabolic function measures will be performed before and after the 10-day intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2018

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 17, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2022

Completed
Last Updated

August 17, 2022

Status Verified

August 1, 2022

Enrollment Period

3.7 years

First QC Date

December 17, 2018

Last Update Submit

August 16, 2022

Conditions

Keywords

arterial stiffnessendothelial dysfunctionfructosephysical inactivity

Outcome Measures

Primary Outcomes (1)

  • Change in Insulin-stimulated leg blood flow

    Subjects will be instrumented with EKG for contrast-enhanced ultrasound (CEU) measurements. We will perform a hyperinsulinemic euglycemic clamp to evaluate microvascular perfusion of skeletal muscle via CEU. Insulin will be infused at a constant rate to mimic postprandial insulin concentrations and glucose maintained at fasting values via a variable 20% dextrose infusion. At baseline and in the steady state phase of the insulin clamp, we will assess microvascular perfusion in the vastus lateralis muscle using CEU (IE-33, Philips Ultrasound), via infusion of perflutren lipid microspheres. Microvascular perfusion will be assessed as an A-value. A is the video intensity plateau after complete replenishment reflecting relative microvascular blood volume (MBV).

    this will be assessed at baseline and at the final visit (10 days)

Secondary Outcomes (2)

  • Change in Brachial artery flow mediated dilation (FMD)

    this will be assessed at baseline and at the final visit (10 days)

  • Change in carotid femoral pulse wave velocity (cfPWV)

    this will be assessed at baseline and at the final visit (10 days)

Study Arms (1)

Fructose and physical inactivity

EXPERIMENTAL

Subjects will consume 6 cans of soda per day and restrict their physical activity.

Other: Fructose and physical inactivity

Interventions

Subjects will drink 6 cans of regular sodas daily (divided throughout the day) and will decreased physical activity to less than 5000 steps daily for 10 days.

Fructose and physical inactivity

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women who regularly engage in \>10,000 steps per day
  • Age 18-45 years
  • Body mass index \< 30 kg/m2
  • No history of chronic disease

You may not qualify if:

  • Known cardiovascular disease including hypertension, heart failure, coronary artery disease, and stroke
  • Renal or hepatic diseases
  • Active cancer
  • Autoimmune diseases
  • Current use of immunosuppressant therapy
  • Excessive alcohol consumption (\> 14 drinks/week for men and \>7 drinks/week for women)
  • Current tobacco use
  • Current pregnancy
  • Diagnosis of type 2 diabetes
  • Regular consumption of \>2 non-diet sodas/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Conditions

Vascular DiseasesSedentary Behavior

Interventions

Fructose

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydratesKetoses

Study Officials

  • Camila Manrique Acevedo, MD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Endocrinology

Study Record Dates

First Submitted

December 17, 2018

First Posted

December 24, 2018

Study Start

November 30, 2018

Primary Completion

August 1, 2022

Study Completion

August 16, 2022

Last Updated

August 17, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations